Skip to the content.

EuroPOND (2016–2020) was an international research team bridging Computer Science and Neurology,
led by University College London.

Funding: EU Horizon 2020, 2016--2020, inclusive

EuroPOND website

For detailed information on our work and team, please visit europond.eu

EuroPOND Software Toolbox

We developed a unified modelling framework for neurological disease progression. Check out the toolbox here.

CompAge 2020

CompAge was a two-day virtual conference on 2 and 3 September 2020, that was originally planned to happen at the ICM Centre for Neuroinformatics in Paris, France.

For on-demand viewing of available content, go here.

This workshop is linked with a dedicated research topic in Frontiers in Artificial Intelligence – Medicine and public health (special issue).

Aims and scope

Ageing is a complex phenomenon that remains poorly understood and raises great challenges for science, medicine, and society. Age-related diseases, such as neurodegenerative diseases, remain largely uncured, with attrition rates in clinical trials reaching unprecedented levels. There is no consensus on prevention measures due to limited understanding of the complex interplay between the multiple manifestations of ageing across scales, systems and organs. The spectrum of possible trajectories of healthy and pathological ageing is extraordinarily entangled, multifactorial, and heterogeneous.

Describing, modelling, and predicting the progression of slowly evolving biological processes requires the development of specific computational and data-driven methods at the cross-roads of biostatistics, machine learning, mathematical modelling, knowledge modeling and numerical simulation.

CompAge 2020 aimed to be a first-of-its-kind forum to communicate recent methodological advances in this field, and foster interactions among researchers from academia, pharmaceutical and technology industries, clinical research, and public health sectors.

Topics of interest included, but were not limited to:

We encouraged contributions from early career researchers from academia and industry.

CompAge 2020 was be the final workshop of the EuroPOND project, funded within the Horizon 2020 program of the European Union, and the follow-up of a disease progression modelling workshop funded by several Innovative Medicines Initiative (IMI) projects.

CompAge 2020 committed to providing an atmosphere that encourages the free expression and exchange of ideas. Consistent with this commitment, CompAge 2020 adopts the Code of Conduct of the MICCAI Society. CompAge 2020 was endorsed by the MICCAI Society.


EuroPOND logo